Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 1,564 | 1,886 | 2,150 | 2,578 | 3,010 |
| Operating Income | -1,564 | -1,886 | -2,150 | -2,578 | -3,010 |
| Other Income | -35 | -66 | 171 | 13 | 74 |
| Pre-tax Income | -1,599 | -1,951 | -1,979 | -2,565 | -2,936 |
| Net Income Continuous | -1,599 | -1,951 | -1,979 | -2,565 | -2,936 |
| Net Income | $-1,599 | $-1,951 | $-1,979 | $-2,565 | $-2,936 |
| EPS Basic Total Ops | -0.31 | -0.27 | -0.47 | -0.51 | -0.50 |
| EPS Basic Continuous Ops | -0.31 | -0.27 | -0.47 | -0.51 | -0.50 |
| EPS Diluted Total Ops | -0.31 | -0.27 | -0.47 | -0.51 | -0.50 |
| EPS Diluted Continuous Ops | -0.31 | -0.27 | -0.47 | -0.51 | -0.50 |
| EBITDA(a) | $-1,536 | $-1,632 | $-2,109 | $-2,532 | $-2,978 |